A reassessment of endothelial injury and arterial lesion formation.
D000818:Animals; D001158:Arteries / Q000293:injuries / Q000473:pathology*; D001161:Arteriosclerosis / Q000209:etiology / Q000473:pathology*; D001777:Blood Coagulation; D002404:Catheterization / Q000009:adverse effects; D002448:Cell Adhesion; D002465:Cell Movement; D002791:Cholesterol, Dietary / Q000633:toxicity; D004727:Endothelium / Q000378:metabolism / Q000473:pathology; D004731:Endotoxins / Q000633:toxicity; D011464:Epoprostenol / Q000096:biosynthesis; D006133:Growth Substances / Q000096:biosynthesis; D007375:Interleukin-1 / Q000502:physiology; D008954:Models, Biological; D009000:Monocytes / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D010982:Platelet-Derived Growth Factor / Q000096:biosynthesis; D011817:Rabbits; D051381:Rats; D013925:Thromboplastin / Q000096:biosynthesis; D014945:Wound Healing
D002791:Cholesterol, Dietary; D004731:Endotoxins; D006133:Growth Substances; D007375:Interleukin-1; D010982:Platelet-Derived Growth Factor; D013925:Thromboplastin; D011464:Epoprostenol